Digital currency may have a limited lifespan but the launch of corporate coins or tokens and the blockchain technology behind it will be winners
Momentum Public Relations
Blog: April 10 2018
If you don’t keep up with the world there is a tendency to be left behind. That thought may come back to haunt those who are scorning the topsy-turvy world of cryptocurrency. Then again the naysayers may be right to scorn digital currencies.
In a CNBC interview aired on January 10, 2018, billionaire investor Warren Buffet, sometimes known as the Oracle of Omaha said that cryptocurrencies are headed for trouble.
“We’ll never have a position in them,” Buffett, chairman and CEO of Berkshire Hathaway, told CNBC’s “Squawk Box.” “I can say with almost certainty that they will come to a bad ending.”
Financial Post columnist Diane Francis sees investing in cryptocurrencies much like investing in Canadian Tire money and the biggest scandal since Bre-X.
Christine Lagarde, head of the International Monetary Fund, believes that unless cryptocurrencies are regulated they will become an oasis for money laundering and a method for financing terrorism.
Cryptocurrencies began life in 2010 when Bitcoins were launched as a digital currency independent of any regulatory agency. To say they have captured the imagination of investors is to understate the situation. According to Digital Trends there are 1,300 cryptocurrencies in existence. Among them are Dash, Ethereum, Einsteinium, Litecoin and Plasma. Some cryptocurrencies have turned out to be nothing more than frauds.
According to the CBC, Canadians lost C$1.7 million dollars to cryptocurrency fraud in 2017, double the amount lost in 2016. And then there are the cyberjackings that take place when cyberminers hijack your computer network and use it to mine bitcoins or some other cryptocurrency. In a Globe and Mail story, Troy Mursch was quoted as saying that up to 50,000 web sites had been taken over to mine cryptocurrencies. These included the websites of the Information and Privacy Commissioner of Ontario and a number of municipal websites.
None of this appears to have quenched investors’ thirst for what some see as a valueless security. On March 23, 2018, The Toronto Star ran a story announcing that the owners of the TSX, TMX Group, through its subsidiary, Shorcan Digital Currency Network, was launching a cryptocurrency brokerage service. The new service will focus on Bitcoins and Ethers.
While people like Diane Francis and Warren Buffet scorn and avoid cryptocurrencies, other believe its time may have come. On February 23, 2018, CNBC published a financial commentary by Julian Hosp called, Five Reasons 2018 could be the best year yet for cryptocurrenices. To be fair, Hosp, who is heavily invested in Bitcoins, has also written a commentary for CNBC called Four triggers could cause a cryptocurrency crash. Hosp knows about cryptocurrency. He cofounded TenX which provides debit cards that people can use to spend their cryptocurrency. TenX has also issued a large Initial Coin Offering or ICO.
ICOs are the way that digital currencies are launched. To say that digital currencies have blown a breath of fresh air through the investment community would be an understatement. In one way or another, individual companies are jumping on the bandwagon and finding ways to take advantage of the situation.
Digital currencies are driven by blockchain technology where separate nodes all store essential ledger information. In order for a transaction to go ahead, it has to be verified in all the nodes. The information is encrypted and there are only two keys. One key is held by the digital currency and one key is held by the individual currency owner. This makes the currency or process tamperproof and provides a secure payment network. The ability to provide a very secure payment network is perhaps the chief attraction of digital currency.
On January 11, 2018, ATWTech, (TSXV:ATW), announced that it had partnered with the Einsteinium Foundation, EMC2 to launch Einsteinium coins, a cryptocurrency. ATWTech is a carrier billing company that is heavily invested in interactive communication. It provides telephone voting services for television shows and texting services that provide appointment alerts to consumers for the Quebec Ministry of Health, among other activities.
In order to diversify its payment options, Voxtel, a subsidiary of ATW Tech, plans to implement EMC2 cryptocurrency in all its platforms such as mobile donations, social communities, messaging, gaming and voice services. The Einsteinium cryptocurrency may as yet, be the only cryptocurrency with an altruistic bent. Its objective is to fund scientific research, advanced IT research and advance cryptocurrency projects.
One of the most interesting developments that digital currency has produced may be its use as a way to finance corporate development. Canadian Oil and Gas junior Hillcrest Petroleum (TSXV: HRH), announced in late January that it has signed an agreement with Entoro Capital to establish a digital Initial Coin Offering, ICO. The Hillcrest digital currency would be based on future revenue from its oil and gas business.
Hillcrest believes that launching an asset backed digital currency could provide it with substantial development funding and open the doors to a broader swath of investors.
As Hillcrest CEO Don Currie said in the press release announcing the decision, “The investment community has been extremely supportive of alternate currencies and Hillcrest looks forward to participating in this new and rapidly evolving investment process.
If the Bitcoin bubble does break, chances are that digital currencies will survive as an alternative financing mechanism when they are backed by real assets, as is the case with Hillcrest.
Relevium Technologies, (TSXV:RLV), a wellness and health care products aggregator, sees a slightly different angle in digital currencies. While it too is contemplating launching an ICO, it appears much more keen to use the blockchain technology that keeps digital currency transactions secure to ensure the security of its online transactions.
Whether or not cryptocurrencies are fated to fall as quickly as they rose is a moot point. On the surface investing in Bitcoins and the like does seem to be an advanced case of the Emperor’s new clothes.
Corporate tokens or coins, on the other hand, may very well have a long life because they are asset based, offer a new financing method for junior companies and in the end may very well prove to be the new form of company shares, with the advantage that you won’t have to go through a stock exchange to purchase or sell them.
Given that cryptocurrencies are havens for fraud and money laundering, that the bubble may or may not burst at any moment, the wise investor may see corporate tokens and blockchain technology companies as the best safe investments in the digital currency environment.
Check out our recent post, A Bitcoin Primer
- Published in Blog
Relevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through European Expansion of Bioganix(R)
Momentum Public Relations
Press Release: April 5 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to announce that it has started the process of establishing European presence for the new Bioganix® brand in partnership with several online partners, including Amazon. Management will be doing an initial launch of eight best selling products, which will be live online on the week of the May 21, 2018 with full marketing launch by mid summer.
Highlights
- Bioganix® has started European expansion with online partners, including Amazon
- Initial launch of eight best selling products the week of May 21, 2018
Impact on the Business
- Presence in Europe adds 83M monthly unique visitors, over 200M new customers and access to 26 European Countries
- Increased competitive advantage and insulation from seasonality in sales
- Building the “trusted” Bioganix® brand equity internationally to a loyal consumer base
Impact on Shareholders
- Management is investing in growing its main retail asset internationally to deliver sustainable value to customers and shareholders alike
- Exposure of RLV to potential European equity investors through its Frankfurt listing
Aurelio Useche, CEO of Relevium, stated: “The decision to expand to Europe was driven by several key indicators including Amazon’s current investment in the region, access to 230M new customers buying online, higher basket sizes and lower competition. We believe the new Bioganix® brand is poised to gain customer acceptance as a “trusted” brand and successful consumer engagement in the European market”
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche
President and CEO
Relevium Technologies Inc.
+1.888.528.8687
Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com
- Published in Relevium Technologies
Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March
Momentum Public Relations
Press Release: April 3 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to report an all-time record high in unit sales for the month of March 2018.
The reported record high of 16,549 units, which was achieved in a seasonally low period, reflects increased online demand for the Bioganix® established product line, which is expected to translate into sales in excess of $439,000 for the month of March. The monthly high did not include the effect from new product launches, which are expected to have an incremental positive impact over the next six months.
The company’s all-time record high of units sold is an important achievement for Relevium’s Bioganix®brand. The Company continues to increase its subscriber base and number of SKUs, now totaling over 230,000 and 38 respectively.
Impact on the Business
- Increase of Bioganix® demand sets the stage for successful launch of new products
- The results indicate that the company’s investment in Mach 2.0 Marketing Engine is starting to pay dividends
Impact on Shareholders
- Increased confidence that management remains engaged on delivering sustainable value to its brands, customers and shareholders
- Incremental value to the acquired Bioganix® business through increased brand equity, exclusive product lines and geographic expansion
- Relevium is steadily building solid base for shareholder value creation, which will deliver future dividends
Abis Hussain, SMO of Relevium, stated: “The implications of this may seem trivial, but the results form this month in a seasonally low period indicate that Mach 2.0 is working as designed. We expect this to also have a positive impact on new products launches over the next six months.”
Aurelio Useche, CEO of Relevium, stated: “This is the first real test of the capabilities of our marketing engine following months of adjustments and beta testing. This small but important success is an important achievement for the company and for our digital marketing and operating teams.”
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche
President and CEO
RELEVIUM TECHNOLOGIES INC
Relevium Technologies Inc.
Aurelio Useche
President and CEO
+1.888.528.8687
investors@releviumcorp.com
www.releviumtechnologies.com
- Published in Relevium Technologies
Relevium Launches New Bioganix Brand Architecture
Momentum Public Relations
Press Release March 29 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to announce it has completed the re-positioning of its Bioganix brand. The new re-positioning enhances Bioganix around the key branding points of Credibility, Quality and Trust. The Company will be rolling out its new brand and new packaging immediately.
The Company is also launching its new website in the first week of April and all new product launches will adopt the guidelines of the new brand architecture that lays out a roadmap to our continued and future success.
Highlights
- Relevium launches new Bioganix brand
- The elevated brand will be catered around Credibility, Quality and Trust
- New Bioganix website launched first week of April
Impact on the Business
- Key differentiation in a very competitive market
- Elevated new brand with premium and exclusive products
- Increased brand equity and recognition
Impact on Shareholders
- Incremental value to the Bioganix assets
- Higher brand recognition = Increased public company awareness
- Steady building of shareholder value for future dividends
Aurelio Useche, CEO of Relevium, stated: “Our team has been working diligently over the last couple of months to launch the newly designed, more recognizable and elevated Bioganix brand,” Mr. Useche stated further: “We are positioning the brand as a recognizable and trusted source of goodness.”
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche
President and CEO
RELEVIUM TECHNOLOGIES INC
Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com
Relevium Technologies Inc.
Aurelio Useche
President and CEO
+1.888.528.8687
- Published in Relevium Technologies
Relevium Announces Initial Launch of Hempco’s PlanetHemp® in the USA
Momentum Public Relations
Press Release: March 13 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (“Relevium”) and Hempco Food and Fiber Inc (TSX VENTURE:HEMP) (‘Hempco’) are pleased to announce the launch of five PlanetHemp® products in the U.S., which are expected to be live the week of March 19, 2018.
Highlights
- Initial launch of five (5) products under the PlanetHemp® brand
- Subsequent additions to the PlanetHemp® product offering in planning stages
- Relevium will launch a Bioganix® Hemp-based Vegan Omega Essential Fatty Acids
Aurelio Useche, CEO of Relevium stated: “Increasing market awareness of the beneficial properties of hemp are creating strong momentum in the food and food additives space. Through our exclusive partnership with Hempco, giving us access to its PlanetHemp® brand, we are exceptionally well positioned to gain market share in this rapidly growing segment of the market. The launch of these products in the United States via Amazon, and in the future on other main sites, such as Jet.com, is an important milestone for both companies. We anticipate this will drive considerable growth and create significant shareholder value for both companies.”
Diane Jang, CEO of Hempco Canada stated: “We are pleased with Relevium’s initiatives towards the launch of the PlanetHemp® products in the U.S. Market. This relationship adds a significant presence on the most important eCommerce channels in the U.S. and we look forward to building a successful long-term and expanding relationship with Relevium.”
The initial launch will comprise of five (5) products, including PlanetHemp® Protein Superfoods and Hemp Seeds.
Relevium will also be launching a Hemp-based Vegan Omega Essential Fatty Acids under its Bioganix® brand.
About Hemp and Derivatives
Hemp is a distinct variety of the Cannabis Sativa plant that is grown specifically for its derived products and applications. Hemp has gained considerable popularity because of its health and wellness effects on humans and pets, primarily due to its well-balanced nutritional value, alkalinity and the presence of cannabidiol, a compound known to promote and support overall health.
According to a recent article published by Forbes, hemp-derived cannabidiol (CBD) is projected to be a billion-dollar market in just three years, according to a new report by Brightfield Group. The data company estimates that hemp CBD sales have already hit $170 million in 2016 and a 55% compound annual growth rate over the next five years will cause the market to crack the billion-dollar mark.
About Hempco
For more than 12 years Hempco has been a trusted and respected pioneer, innovator and provider of premier hemp seed foods. Hempco is committed to developing hemp foods, hemp fiber and hemp nutraceuticals, a “tri-crop” opportunity for producers and processors. Hempco is expanding its processing ability to meet global demands in a 56,000sq. ft. facility located at Nisku, Alberta. Hempco’s common shares trade on the TSX Venture Exchange under the symbol “HEMP”.
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC. | HEMPCO FOOD AND FIBER INC. |
Aurelio Useche | Diane Jang |
President and CEO | CEO |
Relevium Technologies Inc.
+1.888.528.8687
investors@releviumcorp.com
www.releviumtechnologies.com
Hempco Food and Fiber Inc.
John Ross
Chief Financial Officer
+1.647.291.4234
john@hempcocanada.com
- Published in Relevium Technologies
Relevium Appoints Mr. Didier Martin as Blockchain Lead Expert
Momentum Public Relations
Press Release: March 5 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF) and (FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to announce it has appointed Mr. Didier Martin as special advisor and project leader for the Company’s current and future Blockchain projects.
Mr. Didier Martin joins the company effective immediately in his advisory capacity to provide technical leadership over the Company’s current and future Blockchain Technology projects, including advising on all strategic aspects of a potential Token Security Offering (TSO), the integration and positioning of the technology into the Tagspire joint venture and developing use cases for Relevium including the development of a supply chain security private Blockchain solution for the company’s online business.
Aurelio Useche, CEO stated: “In a growing and competitive space like health and wellness, we need to be nimble and able to adopt new technology. Blockchain and Artificial Intelligence are examples of useful and applicable technologies we can integrate to provide a competitive advantage to our business”. Mr. Useche stated further: “We can either take a lead and open ourselves today to the blue-sky that these technologies can provide, OR we can become followers and late adopters. The choice to us is very clear”
Mr. Didier Martin serves currently as Lead Expert at Interblockchain.io, a solution capable of interconnecting heterogeneous Blockchain allowing free cryptocurrencies movements between Bitcoin, Bitcoin Cash, Litecoin, Ethereum, Neo, EOS and his experience is well aligned to provide a solid ground for the Company’s plans in this space. Mr. Martin has 30 years’ experience in the management of technology, security and software development. Mr. Martin has also held senior executive roles in several start-ups, public companies and consortiums.
Aurelio Useche, CEO stated: “We are honoured to have Didier as our Blockchain lead expert. Our entire team extends a warm welcome to Mr. Martin and look forward to identifying opportunities and use cases for our business”
The appointment of a Blockchain expert solidifies Relevium’s commitment to accomplish everything set forth in the H2 guidance and to ensure the best talent and partners within the industry, as the Company continues to grow its business.
About Blockchain Technology
Blockchain is a transparent and incorruptible digital ledger that can be applied to any transaction of value. This digital ledger is a dynamic growing list of records (blocks) linked to each other and encrypted for security. In addition to security, Blockchain enables the use of smart contracts, which are self-automated computer programs that can carry out the terms of any contract or transaction. Blockchain is the underlying technology behind cryptocurrencies.
“…the most critical area where Blockchain helps is to guarantee the validity of a transaction by recording it not only on a main register but a connected distributed system of registers, all of which are connected through a secure validation mechanism.” Ian Khan, TEDx Speaker, Author and Technology Futurist
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche, President and CEO
Relevium Technologies Inc.
+1.888.528.8687
investors@releviumcorp.com
www.releviumtechnologies.com
- Published in Relevium Technologies
Relevium Provides H2 Guidance for Bioganix, Acquisitions and Legal Hemp Derivatives
Momentum Public Relations
Press Release: March 2 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to provide guidance on its strategy for its core e-commerce business for the second half of fiscal year ending June 30, 2018.
Highlights
- Bioganix® strategy and revenue expansion
- Official launch of Planet Hemp products
- Introduction and launch of Heart and Eye Health Omega 7 products
- Guidance on legal hemp derivatives for nutraceutical and skin care
- Launching of first pet care product
- European expansion of Bioganix brand
- Strategy and guidance for actionable M&A opportunities
Bioganix Strategy and Revenue Expansion
The Company has shifted its focus from daily operations optimization to increasing brand value. As such, Bioganix® is undergoing a major brand facelift which will better represent the values presentation and promise to our growing customer base. Words like Credibility, Quality, Trust, Elevated, Accessible, Centered, Confident, Wellness and Self-Actualization will be at the core of the new presentation to the market, with the objective at seeking higher conversion rates and brand loyalty within a more informed and wider audience base.
Relevium has been working with a newly extended supplier base and intends to launch sixteen (16) new products under the Bioganix® product brand before June 30, 2018. These new products will represent the first set of products launched entirely by the Relevium Operations Team since taking control of the business in July of 2017.
Official Launch of Planet Hemp Products
Since signing the exclusive product agreement with Hempco and PlanetHemp, the Company has been working closely with the team at Hempco to launch the PlanetHemp brand in Amazon US and UK. The team at Relevium will be launching five (5) PlanetHemp products in in H2 2018.
Abis Hussain, Senior Marketing Officer at Relevium stated: “We are seeing a huge appetite for hemp nutrition, skin care and hemp derived CBD products selling in legal jurisdictions online, both in the UK and US.” Mr. Hussain continued: “With increasing media exposure and regulatory changes, consumers are looking for hemp-based products to add them to their wellness programs. We feel that we are in the right position to capitalize on this segment.”
Introduction and launch of Heart and Eye Health Omega 7 products
Following the signing of the exclusivity agreement with Tersus for Provinol Ultra-Purified Omega 7products, the Company is in the process of building a premium brand and online assets for a new line of research-based vegan and fish oil based product line. The Omega 7 products for Heart and Vision will be the first of a series of products that will be launched and marketed as a premium product.
Mr. Hussain stated: “Omega products sell extremely well online. We are well positioned with exclusive and premium products like Ultra-Purified Omega 7, and our team is confident that a premium brand strategy will deliver optimal value to Relevium. The new premium brand will allow us to market products to a new demographic and market segment that is diversified from the Bioganix® core brand.”
Guidance on legal hemp derivatives for nutraceutical and skin care
Relevium has seen an increase in online content and traffic for hemp and hemp derivatives such as CBD. The market place is changing fast and the rate of adoption as well. In advance of fully launching products, brands and new business segments, the Company has begun accumulating a portfolio of domain names and is also building online assets for an elevated an trusted brand in the space.
The Company has been actively qualifying various suppliers, vendors, products and research partners in the space and believes that launching products within the legal hemp derivative market in H2 2018 is feasible.
Management is working with its legal counsel to ensure full compliance within a fast-evolving space. In order to ensure compliance for online retail, the company has engaged experts to build a private Blockchain with the objective of supporting and ensuring compliance in the entire supply chain.
Mr. Useche stated: “We have been actively monitoring and working in this market. We are cognisant that e-commerce for hemp and hemp derivatives for over-the-counter and prescription formulations will be an enormous market. We believe to have the initial based to ensure we position an elevated, trusted and compliant Relevium brand in this space.”
Execution of product launches in the hemp, hemp derivatives including CBD will be dependent on compliance with laws and regulations in each jurisdiction and each e-commerce platform where products are to be offered.
Launching of first pet care product
Relevium previously announced the creation of a segment of pet-focused products. The Company expects to launch its first products to include research-based joint and brain health formulations, both products currently trending online in 2018.
European expansion of Bioganix brand
The Company has been working on building out distribution for the European Union (“E.-U.”), notably in the United Kingdom, Germany, France, Spain and Italy. Initially focused on the geographical expansion of the BioGanix brand, Relevium will launch brands and products in the E.-U. as permitted by law.
Strategy and guidance for actionable M&A opportunities
The Company’s acquisition strategy is now focused on three main parameters: (1) strategic fit, (2) diversification and (3) accionability, the latter greatly dependent on market conditions, deal structure and our own valuation in the market. The main objective is ensure that we deliver a target that adds value to the portfolio and is well structured to limit the dilution effect.
The pipeline for acquisitions has been as high as USD 120,000,000 in cash flows to acquire. Depending on marketplace fluctuations, the pipeline is rarely lower than USD 50,000,000 in cash flow to acquire.
Mr. Useche stated: “The acquisition parameters from inception have been clear: we want to buy assets with high margins and pay low multiples, but there must be strategic fit and brand value add to our current business. We remain very active and in discussions but have yet to find the perfect candidate for our second acquisition that meets our more stringent selection process.”
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche
President and CEO
Relevium Technologies Inc.
+1.888.528.8687
investors@releviumcorp.com
www.releviumtechnologies.com
- Published in Relevium Technologies
Relevium Operational Update and Investments for Financial H1 2018
Momentum Public Relations
Press Release: February 28 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the “Company” or “Relevium”), is reporting on an operational update and areas of investment for financial Q2 2018 (October 1, 2017 to December 31, 2017).
Aurelio Useche, President and CEO of Relevium stated: “The integration, optimization and scale up of BioGanix since acquisition has gone as expected.” Mr. Useche continued: “Operationally we expected a learning curve and expected to overcome all challenges. I think the Operations Team has overcome all challenges and the Company is poised to drive growth in the 2018 calendar year. The e-commerce landscape for nutraceuticals is under constant change and we have been quick on our feet to adapt and maintain sales velocity.”
During the first six (6) months of operating BioGanix, the Company has focused on transitioning the business, accounts and assets. Following the successful transition which lasted until roughly November 1, 2017, the Company built up an internal Operations Team which subsequently set forth to optimize the business predominantly through conceptualization and deployment of the Mach 2.0 Marketing Engine. During this period, the Company did experience a temporary decrease in revenue.
Since October 1, 2017 the Company has invested over CAD $250,000 for building out the infrastructure and acquiring the talent necessary to drive future growth of the BioGanix brand. These investments in technology, people and commercial agreements will also be integral in allowing the Company to execute on the plethora of product and brand launches it has planned for the 2018 calendar year.
The Company expects to launch no less than three (3) new brands and over twenty (20) new products or SKUs in 2018. Launches will begin as soon as March 2018. The Company will provide further detail to this effect in a forthcoming news release.
Mr. Abis Hussain, Senior Marketing Officer of Relevium Technologies: “We are really excited to start launching products. The Company has yet to launch products that fully reflect our collective efforts. The products that we will bring to market this year will really show our ability to find and market exclusive products. Prior to this, everything being marketed was part of the classic line launched by the previous BioGanix team. We believe our true colors and grit are about to shine.”
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Relevium Technologies Inc. has provided further clarifications on its press release from earlier on Feb. 23, 2018.
The company has received several requests from active shareholders to clarify ambiguity in the language of the operational press release from earlier in the day.
Aurelio Useche, president and chief executive officer of Relevium, stated, “The company is very appreciative of the feedback from its shareholders who asked us to provide clarity over the press release.”
The first six months of operations have been successful in all fronts, including sales revenue, which have continued to demonstrate an overall positive direction ahead of previous periods.
The company did highlight in the previous news release a revenue decline, which was in reference to the month of November. The decline was related to product adjustments and changes in marketing costs due to the implementation of the automation process. However, overall revenues for the six-month period were on target.
The following is a summary of the message that was intended by the company to communicate to shareholders:
- The integration, optimization and scale-up of BioGanix since acquisition have been successful and as expected. The transition period included an expected learning curve, and the operating team has done very well in meeting the challenge.
- Sales revenues are on target and ahead of last year’s results by the previous ownership.
- The company has made several important investments, not only to optimize current operations, but also to prepare the team for organic and acquisition-based growth.
The following were also important updates management felt key to convey to its shareholder base:
- The eventual launch of three new brands, the culmination of the successful exclusivity agreements entered into by the company during the reporting;
- The launch of over 20 new products or SKUs (stock-keeping units) in 2018 expected to hit the shelves as soon as March, 2018.
Management looks forward to reporting Q2 2018 financial results next week.
- Published in Relevium Technologies
Relevium Commences Trading on OTCQB
Momentum Public Relations
Press Release: February 20 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to announce that it has commenced trading on the OTCQB under the symbol RLLVF
Aurelio Useche, President and CEO of Relevium stated: “We have been focused on an industry and technologies that, from our analytics resonate very well in the U.S. market as that is the point of origin and a major market for e-commerce.” Mr. Useche continued: “Relevium is in the business of marketing products and brands. Our stock, our corporate vision is no different. Our core operational efforts have and will remain in the U.S. and it is only natural that we leverage that exposure with an OTCQB listing.”
The OTCQB Venture Market is for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.
Relevium Technologies will continue to trade and report on the TSX Venture Exchange under its existing symbol RLV.
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche, President and CEO
For more information about this press release:
Relevium Technologies Inc.
+1.888.528.8687
investors@releviumcorp.com
www.releviumtechnologies.com
- Published in Relevium Technologies
Relevium Improves Financial Position and Provides Updates on Warrants Exercises and Share for Services Agreement
Momentum Public Relations
Press Release: February 5, 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the “Company” or “Relevium”) is pleased to report improvements on its financial position, provide an update on warrants exercised to date and on shares issued to its corporate secretary on a share for services agreement.
Improved Financial Position and Warrants Exercises to-date
The company has received warrant and options exercises and issued 13,591,361 shares at a weighted average price of $0.15, resulting in total cash proceeds of $2,008,704. Aurelio Useche, CEO stated: “Combined with the debt conversion announced on December 12, 2017, the company has significantly improved its financial position. We want to thank our loyal shareholders for their support and loyalty as we pursue our objectives in 2018.”
Shares Issued to Corporate Secretary per Share for Services Agreement
The company also announced it has issued 27,300 shares on Friday February 2, 2018 at a deemed price of $0.183146 per share to the Company’s Corporate Secretary, Mr. David A. Johnson, pursuant to a shares-for-services agreement disclosed in a company press release dated October 20, 2017. The shares are subject to a four month hold period. Pricing was determined using the VWAP on the close of February 2, 2018.
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche, President and CEO
Relevium Technologies Inc.
Edward Ierfino
Investor Relations
+1(514) 562-1374
eierfino@releviumcorp.com
www.releviumtechnologies.com
- Published in Relevium Technologies